A detailed history of Principal Financial Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 6,032,255 shares of MRK stock, worth $747 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
6,032,255
Previous 5,911,682 2.04%
Holding current value
$747 Million
Previous $644 Million 23.5%
% of portfolio
0.49%
Previous 0.43%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$113.24 - $131.95 $13.7 Million - $15.9 Million
120,573 Added 2.04%
6,032,255 $796 Million
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $2.01 Million - $2.18 Million
20,018 Added 0.34%
5,911,682 $644 Million
Q3 2023

Nov 02, 2023

BUY
$102.95 - $114.33 $836,159 - $928,588
8,122 Added 0.14%
5,891,664 $607 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $67.7 Million - $73.7 Million
-622,878 Reduced 9.57%
5,883,542 $679 Million
Q1 2023

May 09, 2023

SELL
$102.94 - $114.86 $1.5 Million - $1.67 Million
-14,530 Reduced 0.22%
6,506,420 $692 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $20.5 Million - $26.3 Million
-234,630 Reduced 3.47%
6,520,950 $723 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $2.82 Million - $3.16 Million
-33,308 Reduced 0.49%
6,755,580 $582 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $56.9 Million - $64.5 Million
-681,164 Reduced 9.12%
6,788,888 $619 Million
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $29.8 Million - $33.4 Million
405,264 Added 5.74%
7,470,052 $613 Million
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $22.9 Million - $28.7 Million
-316,454 Reduced 4.29%
7,064,788 $541 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $11 Million - $12.1 Million
154,016 Added 2.13%
7,381,242 $554 Million
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $32.6 Million - $36.1 Million
464,160 Added 6.86%
7,227,226 $562 Million
Q1 2021

May 10, 2021

SELL
$68.86 - $81.11 $25.9 Million - $30.5 Million
-376,402 Reduced 5.27%
6,763,066 $521 Million
Q4 2020

Feb 23, 2021

SELL
$71.77 - $79.65 $1,004 - $1,115
-14 Reduced -0.0%
7,139,468 $584 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $3.38 Million - $3.76 Million
-47,145 Reduced 0.66%
7,139,482 $584 Million
Q3 2020

Nov 06, 2020

SELL
$73.18 - $82.95 $14.8 Million - $16.8 Million
-202,599 Reduced 2.74%
7,186,627 $569 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $30.3 Million - $34.4 Million
429,690 Added 6.17%
7,389,226 $571 Million
Q1 2020

May 12, 2020

SELL
$63.36 - $87.82 $5.22 Million - $7.23 Million
-82,383 Reduced 1.17%
6,959,536 $535 Million
Q4 2019

Feb 05, 2020

SELL
$77.58 - $87.54 $25.3 Million - $28.6 Million
-326,374 Reduced 4.43%
7,041,919 $640 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $2.76 Million - $3 Million
36,214 Added 0.49%
7,368,293 $620 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $5.27 Million - $6.16 Million
75,453 Added 1.04%
7,332,079 $615 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $3.06 Million - $3.49 Million
-43,937 Reduced 0.6%
7,256,626 $604 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $3.05 Million - $3.54 Million
-46,773 Reduced 0.64%
7,300,563 $558 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $10.8 Million - $12.6 Million
-186,436 Reduced 2.47%
7,347,336 $521 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $16.9 Million - $19.8 Million
331,583 Added 4.6%
7,533,772 $0
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $10.7 Million - $12.4 Million
209,459 Added 3.0%
7,202,189 $392 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $7.25 Million - $8.66 Million
140,538 Added 2.05%
6,992,730 $393 Million
Q3 2017

Nov 02, 2017

BUY
$58.67 - $63.13 $402 Million - $433 Million
6,852,192
6,852,192 $439 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.